ClinicalTrials.gov
ClinicalTrials.gov Menu

Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00263432
Recruitment Status : Unknown
Verified December 2014 by University Hospital, Ghent.
Recruitment status was:  Recruiting
First Posted : December 8, 2005
Last Update Posted : December 5, 2014
Sponsor:
Collaborator:
University Ghent
Information provided by (Responsible Party):
University Hospital, Ghent

Brief Summary:
Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries to obtain a repair and prevention of secondary osteoarthritis

Condition or disease Intervention/treatment Phase
Cartilage Injuries in the Human Knee Procedure: Human allogenic chondrocytes Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Reparation of Cartilage Injuries in the Human Knee by Implantation of Fresh Human Allogenic Chondrocytes
Study Start Date : August 2011
Estimated Primary Completion Date : July 2015
Estimated Study Completion Date : July 2015

Arm Intervention/treatment
Experimental: 1
Implantation of fresh human allogenic chondrocytes
Procedure: Human allogenic chondrocytes
Implantation of fresh human allogenic chondrocytes in human knee cartilage injuries



Primary Outcome Measures :
  1. Healing of the cartilage injuries [ Time Frame: After 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Important cartilage injury in the knee

Exclusion Criteria:

  • Important axis deviation
  • Inflammatory joint disorder
  • Severe obesity

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00263432


Contacts
Contact: Karl Fredrik Almqvist, MD, PhD fredrik.almqvist@UGent.be

Locations
Belgium
University Hospital Ghent Recruiting
Ghent, Belgium, 9000
Contact: Karl Fredrik Almqvist, MD, PhD       fredrik.almqvist@UGent.be   
Sponsors and Collaborators
University Hospital, Ghent
University Ghent
Investigators
Principal Investigator: Karl Fredrik Almqvist, MD, PhD University Hospital, Ghent

Additional Information:
Responsible Party: University Hospital, Ghent
ClinicalTrials.gov Identifier: NCT00263432     History of Changes
Other Study ID Numbers: 2001/245
First Posted: December 8, 2005    Key Record Dates
Last Update Posted: December 5, 2014
Last Verified: December 2014

Additional relevant MeSH terms:
Wounds and Injuries